A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.
Daily News Roundup
A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.
After years of complaints, the European Commission proposes ways to fix its system in an effort to reinvigorate research on the continent.
The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.
A postdoctoral research fellow at Emory University falsifies stem cell research data.
According to a new report, the US Fish and Wildlife Service ignored science advisors and shrunk protected habitats for endangered species from 2002 to 2007.
An advisory committee urges the federal funding agency to take steps to counter racial bias in the granting process.
A public interest legal group has renewed the fight against DNA patenting.
The UK government releases its recommendation that open access be “the main vehicle for the publication of research,” though it warns of the costs that could entail.
The Senate approves an increase of about 0.3 percent for the 2013 NIH budget, but the Department of Energy doesn’t fare as well.
A United Kingdom ethics council approves altering human egg cells, which could allow doctors to correct mitochondrial disease in IVF patients.